Furthermore, for each of these miRNAs, the area under the ROC curve (AUROC) was 0.91 to 1.00 for the SS or NASH diagnostic group (Fig 5B); these results indicated that each of the Dlk1-Dio3 mat NAFLD candidate miRNAs provided good diagnosis accuracy with regard to distinguishing between SS and NASH for NAFLD patients. This evidence concerns the gene DLK1 and metabolic dysfunction-associated steatotic liver disease.